Literature DB >> 7881406

DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.

F Squitieri1, S E Andrew, Y P Goldberg, B Kremer, N Spence, J Zeisler, K Nichol, J Theilmann, J Greenberg, J Goto.   

Abstract

This study of allelic association using three intra- and two extragenic markers within 150 kb of the Huntington disease (HD) mutation has provided evidence for linkage disequilibrium for four of five markers. Haplotype analysis of 67 HD families using markers in strong linkage disequilibrium with HD identified two haplotypes underlying 77.6% of HD chromosomes. Normal chromosomes with these two haplotypes had a mean number of CAG repeats significantly larger than and an altered distribution of CAG repeats compared with other normal chromosomes. Furthermore, haplotype analysis of five new mutation families reveals that HD has arisen on these same two chromosomal haplotypes. These findings suggest that HD arises more frequently on chromosomes with specific DNA haplotypes and higher CAG repeat lengths. We then studied CAG and CCG repeat lengths in the HD gene on 896 control chromosomes from different ancestries to determine whether the markedly reduced frequency of HD in Finland, Japan, China and African Blacks is associated with an altered frequency of DNA haplotypes and subsequently lower CAG lengths on control chromosomes compared to populations of Western European descent. The results show a highly significant inverse relationship between CAG and CCG repeat lengths. In populations with lowered prevalence rates of HD, CAG repeat lengths are smaller and the distribution of CCG alleles is markedly different from Western European populations. These findings suggest that, in addition to European emigration, new mutations make a contribution to geographical variation of prevalence rates and is consistent with a multistep model of HD developing from normal chromosomes with higher CAG repeat lengths.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7881406     DOI: 10.1093/hmg/3.12.2103

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Key role of nuclear medicine in seeking biomarkers of Huntington's disease.

Authors:  Ferdinando Squitieri; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 3.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

4.  The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.

Authors:  Maria do Carmo Costa; Paula Magalhães; Laura Guimarães; Patrícia Maciel; Jorge Sequeiros; Alda Sousa
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

5.  Clinical utility gene card for: Huntington's disease.

Authors:  Carsten Saft; Blair R Leavitt; Jörg T Epplen
Journal:  Eur J Hum Genet       Date:  2013-10-09       Impact factor: 4.246

Review 6.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

7.  Update on genetics of Huntington's disease: availability of direct and accurate predictive test.

Authors:  F Squitieri; G Campanella; M R Hayden
Journal:  Ital J Neurol Sci       Date:  1996-06

8.  Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.

Authors:  M Cossée; M Schmitt; V Campuzano; L Reutenauer; C Moutou; J L Mandel; M Koenig
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

9.  Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon.

Authors:  G Stevanin; A S Lebre; C Mathieux; G Cancel; N Abbas; O Didierjean; A Dürr; Y Trottier; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

10.  Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.

Authors:  Irene Paradisi; Alba Hernández; Sergio Arias
Journal:  J Hum Genet       Date:  2007-12-22       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.